|
Early data show potential for imatinib to treat life-threatening form of pulmonary artery disease
|
13 October 2008 |
|
Novartis decides not to pursue further development of Aurograb(TM)
|
02 September 2008 |
|
Significant blood pressure reductions seen with Exforge across difficult-to-treat groups
|
30 July 2008 |
|
Novartis gains momentum with strong performance in first half of 2008
|
19 July 2008 |
|
Novartis completes acquisition of 25% stake in Alcon from Nestlé
|
09 July 2008 |
|
Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
|
07 July 2008 |
|
Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development
|
27 June 2008 |
|
Novartis reports higher sales and earnings in first quarter of 2008
|
24 April 2008 |
|
Novartis announces 20% average reduction in price of malaria drug Coartem®
|
24 April 2008 |
|
FTY720, a novel oral therapy in development for multiple sclerosis
|
21 April 2008 |